-
Products_type
Antibody
-
Products_short_name
[c-Myb Oncoprotein]
-
Products_name_syn
[c-myb_CDS; efg; ONCOGENE AMV; Oncogene MYB; Proto-oncogene c-Myb; Transcriptional activator Myb; v-myb avian myeloblastosis viral oncogene homolog]
-
Other_names
[transcriptional activator Myb isoform 3; Transcriptional activator Myb; transcriptional activator Myb; c-myb8B_CDS; c-myb10A_CDS; c-myb13A_CDS; c-myb14A_CDS; proto-oncogene c-Myb; c-myb protein (140 AA); v-myb avian myeloblastosis viral oncogene homolog; Proto-oncogene c-Myb]
-
Products_gene_name
[MYB]
-
Other_gene_names
[MYB; MYB; efg; Cmyb; c-myb; c-myb_CDS]
-
Clonality
Monoclonal
-
Clone
[MYB286]
-
Reactivity
Human.
-
Specificity
The highly leukemogenic avian retrovirus E26 contains two oncogenes, v-Myb and v-Ets, which are expressed together as a fusion protein. The cellular hom- olog of v-Myb, designated c-Myb, encodes a transcription factor. Deletion or disruption of a negative regulatory domain mapping within the carboxy-ter- minal domain of c-Myb results in enhanced transactivating capacity and in parallel, leads to activation of its ability to transform hemopoietic cells. c-Myb is expressed preferentially, but not exclusively, in immature hemopoietic cells and its expression decreases as cells differentiate.
-
Form
200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
-
Storage_stability
Store at 2 to 8 degree C. Antibody is stable for 24 months.
-
Tested_application
ELISA (EIA), Flow Cytometry (FC/FACS), Immunofluorescence (IF), Western Blot (WB), Immunoprecipitation (IP), Immunohistology (IH)
